Log in
Enquire now
Alyssum Therapeutics

Alyssum Therapeutics

Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.

OverviewStructured DataIssuesContributors

Contents

alyssumtx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Pharmaceutical industry
Pharmaceutical industry
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
B2X
B2B
B2B
CEO
‌
Richard Fahrner
Number of Employees (Ranges)
1 – 10
Investors
Patrick Soon-Shiong
Patrick Soon-Shiong
Navam Capital
Navam Capital
Accel
Accel
Total Funding Amount (USD)
26,000,000
Latest Funding Round Date
October 23, 2024
CTO
‌
Richard Fahrner
Latest Funding Type
Series A
Series A

Other attributes

Latest Funding Round Amount (USD)
26,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Alyssum Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.